DO
Therapeutic Areas
IceCure Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ProSense® Breast Cryoablation | Low‑risk early‑stage breast cancer (≤1.5 cm, ER⁺/PR⁺/HER2⁻, Ki‑67 < 15 %) | FDA‑cleared (commercial) |
| ProSense® Kidney Cryoablation | Renal cell carcinoma ≤5 cm | CE‑marked, FDA‑cleared (commercial) |
| ProSense® Lung Cryoablation | Stage I non‑small cell lung cancer (T1N0M0) | CE‑marked, clinical registry |
| ProSense® Fibroadenoma Ablation | Benign breast fibroadenomas | CE‑marked |
| ProSense® Palliative Cryoablation | Symptom control for metastatic lesions | Clinical use |